Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22789,97,0.99 [0.70-1.38],0.932826277667084
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23413,178,1.13 [0.91-1.40],0.2784519958602981
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23185,1137,1.00 [0.91-1.10],0.9901419200264024
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Candidiasis,23444,408,1.07 [0.92-1.25],0.3812869738706804
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22711,2985,1.02 [0.96-1.08],0.4872284401331055
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22910,2418,1.09 [1.02-1.16],0.0070359175809915
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23197,1140,1.00 [0.90-1.10],0.934109323000018
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23340,79,1.18 [0.86-1.60],0.3055638722319096
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21891,685,1.03 [0.92-1.17],0.5848074618195692
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21143,784,1.08 [0.97-1.20],0.1773157704756876
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21201,218,1.05 [0.85-1.30],0.6647217526492388
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16435,1389,1.09 [1.01-1.18],0.0308133251902893
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21008,313,1.07 [0.89-1.27],0.4772178278966427
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23381,1324,1.02 [0.93-1.11],0.718215166932896
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Mycoses,23495,459,1.07 [0.93-1.24],0.3206887899529603
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22850,802,1.05 [0.94-1.17],0.413266110695164
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23444,752,1.06 [0.94-1.18],0.3558911184622572
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22235,178,1.13 [0.91-1.40],0.2816054876411999
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23548,35,1.29 [0.85-1.95],0.2380252303035659
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23356,664,1.03 [0.91-1.17],0.6399980906949105
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23336,75,1.16 [0.84-1.61],0.3653995223081313
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23463,164,1.04 [0.81-1.32],0.7805282675402596
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23449,150,1.00 [0.77-1.30],0.9861099185560546
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22338,290,0.98 [0.81-1.19],0.8276108020240168
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22270,222,0.87 [0.68-1.11],0.2465391812328046
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22153,96,1.22 [0.93-1.59],0.1510915676877395
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23525,33,1.19 [0.74-1.90],0.4728421072142893
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23484,141,0.97 [0.73-1.28],0.8223940913701677
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral warts,23384,41,0.88 [0.50-1.55],0.6648303839955998
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23414,71,0.91 [0.60-1.38],0.6490189490371391
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm,23317,201,1.02 [0.81-1.28],0.8612190099794725
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23460,57,1.14 [0.78-1.67],0.4937418326826041
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23455,58,1.25 [0.89-1.74],0.1926061438816588
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23300,1042,1.02 [0.92-1.13],0.6907556450691275
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of meninges,23524,72,1.07 [0.75-1.55],0.7003618095802882
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23489,57,1.23 [0.87-1.74],0.2312438209151662
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23518,107,1.27 [1.00-1.62],0.0498552272632384
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of ovary,23480,148,0.84 [0.62-1.14],0.2661313168540165
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23528,235,0.84 [0.66-1.07],0.1540215405164242
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Caecum,23534,214,0.86 [0.67-1.10],0.2269914399869636
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23468,54,1.10 [0.74-1.64],0.6373121501051515
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Descending colon,23533,131,0.92 [0.68-1.26],0.6091731837469097
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Rectum,23494,239,0.79 [0.62-1.01],0.062389622697337
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23452,437,1.03 [0.89-1.20],0.6921922745749232
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23534,252,1.20 [1.02-1.43],0.0324081572708927
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Carcinoma in situ of breast,19054,119,0.81 [0.57-1.15],0.2428575880922644
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19126,138,0.81 [0.59-1.12],0.2025062051457737
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19121,30,0.87 [0.45-1.70],0.687441925921598
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19147,56,1.08 [0.72-1.61],0.7204526715768816
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23484,124,1.01 [0.75-1.35],0.9547035617537604
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma, any site",23485,122,1.00 [0.74-1.34],0.9754829638794976
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Leiomyoma of uterus,22685,498,0.98 [0.85-1.14],0.7838949089998319
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lung cancer and mesothelioma,16927,277,1.01 [0.83-1.25],0.8899362357216449
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lymphoid leukaemia,19125,34,0.89 [0.48-1.64],0.7027948764387162
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19243,152,1.04 [0.81-1.34],0.7512489501428177
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19186,95,1.04 [0.76-1.44],0.7890254422974997
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19251,160,1.04 [0.81-1.34],0.7424149482816406
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19152,61,1.06 [0.71-1.58],0.766604446694479
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19152,61,1.03 [0.68-1.54],0.9024091181713676
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19137,46,1.09 [0.69-1.71],0.7156187717565166
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19220,129,1.16 [0.91-1.49],0.2394804331022406
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19180,89,1.30 [1.00-1.68],0.0500910345346338
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19162,71,1.06 [0.73-1.53],0.7681024939521696
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19126,35,1.24 [0.81-1.92],0.3253636385788798
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19160,69,0.76 [0.47-1.21],0.2460472795493592
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi,23318,195,1.16 [0.95-1.42],0.1367096461701658
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi of trunk,23508,66,1.12 [0.79-1.60],0.5171719855759896
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanoma in situ,19119,72,1.00 [0.68-1.47],0.9954353826905558
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19161,70,1.17 [0.84-1.63],0.3510761861302621
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19219,128,1.23 [0.98-1.54],0.0805917273123105
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19293,202,0.84 [0.65-1.09],0.1984040626625227
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19171,80,1.35 [1.05-1.74],0.0174771930815172
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Other benign neoplasms of skin,23351,151,1.21 [0.98-1.50],0.0757467675168456
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19884,793,1.00 [0.89-1.12],0.9876466051774938
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19918,827,1.02 [0.91-1.14],0.7830551201985638
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23273,336,1.07 [0.90-1.26],0.4634589093529427
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21837,84,0.82 [0.54-1.24],0.349709272416838
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23007,70,1.24 [0.91-1.68],0.1738336445592245
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22681,2535,1.08 [1.02-1.15],0.0121103677543653
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22166,27,0.95 [0.49-1.82],0.8680541777706333
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23207,43,1.65 [1.29-2.11],5.3843178658733525e-05
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23046,1293,1.05 [0.96-1.15],0.277960279907864
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23046,1293,1.05 [0.96-1.15],0.277960279907864
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21820,67,1.12 [0.79-1.60],0.5249791434500598
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23192,1053,1.11 [1.02-1.22],0.0218467424304584
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23264,100,1.19 [0.90-1.57],0.2225231951556272
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22982,45,1.14 [0.74-1.76],0.544753298267826
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22988,51,1.24 [0.86-1.78],0.2521422210661963
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23365,201,1.12 [0.91-1.38],0.2976327626666475
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23455,51,1.20 [0.82-1.75],0.3416016067098061
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23337,173,1.00 [0.78-1.28],0.9992002825343091
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22253,114,0.90 [0.65-1.26],0.5481045810396348
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18991,202,1.03 [0.82-1.30],0.7693793471241444
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22322,57,1.05 [0.71-1.57],0.8007757363965906
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22318,53,1.63 [1.37-1.93],3.89228891413797e-08
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18832,43,1.23 [0.82-1.83],0.3105809242789304
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21590,55,1.32 [0.98-1.77],0.0671739804191504
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21313,205,1.03 [0.83-1.29],0.7732482740705875
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23174,411,0.91 [0.76-1.08],0.2738753673443577
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23018,255,0.86 [0.68-1.08],0.1867026099700753
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22824,61,0.84 [0.52-1.35],0.4789577020169265
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23217,1682,1.07 [1.00-1.16],0.0601226787627825
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20882,1643,1.08 [1.01-1.17],0.034605615174883
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18833,44,1.14 [0.73-1.77],0.5681378086071239
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20937,99,1.04 [0.76-1.44],0.7916209829322634
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19025,236,1.22 [1.03-1.46],0.0239690910411164
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18830,41,1.33 [0.92-1.92],0.1271877009042086
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21478,2689,1.14 [1.07-1.20],1.081826006024218e-05
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18971,182,1.08 [0.86-1.36],0.5111099924756374
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19252,463,1.18 [1.03-1.34],0.0137125024226762
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23464,303,1.20 [1.03-1.40],0.0205950409067194
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23302,141,1.33 [1.10-1.62],0.004019880691905
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18878,89,1.12 [0.82-1.54],0.4814764628341343
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18839,50,1.40 [1.03-1.91],0.0329126008081301
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22793,1955,1.06 [0.99-1.14],0.1138117278444622
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18959,170,1.11 [0.87-1.40],0.4006312408253432
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18957,168,1.22 [0.99-1.51],0.0651002648724188
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19246,457,1.16 [1.01-1.33],0.0379247474035348
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18857,68,1.06 [0.72-1.56],0.773344813764304
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23297,136,1.31 [1.07-1.61],0.0096981888012793
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19319,530,1.02 [0.88-1.17],0.7929168221774284
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19262,473,1.07 [0.93-1.23],0.3669937236881245
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21171,63,1.24 [0.89-1.71],0.2030953522708035
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22799,4010,1.11 [1.06-1.16],1.8512985352622143e-05
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20901,63,0.71 [0.43-1.18],0.1863364552461305
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20913,75,1.25 [0.93-1.67],0.1356212667386657
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23380,1758,0.98 [0.91-1.07],0.7029435078759778
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23384,1757,0.98 [0.91-1.07],0.6891013668301221
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20912,74,1.10 [0.78-1.56],0.5874537174074426
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23191,1353,1.09 [1.00-1.18],0.0407167356843958
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20061,1272,1.07 [0.98-1.16],0.1606822003940188
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23538,154,1.10 [0.86-1.40],0.4639879605463803
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22801,38,0.85 [0.47-1.54],0.6010476082058684
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21955,117,1.26 [1.00-1.59],0.0531079835039505
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22006,168,1.11 [0.89-1.40],0.3568013172442859
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19003,214,1.22 [1.01-1.46],0.0360225251356986
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21981,120,1.41 [1.15-1.72],0.0010893272941529
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1465,37,0.70 [0.36-1.38],0.3038594938231916
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1557,147,1.14 [0.92-1.41],0.2449131830426668
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21886,25,1.33 [0.81-2.19],0.2626988160261042
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1450,23,0.69 [0.29-1.65],0.3992207509304545
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23143,1282,1.00 [0.91-1.10],0.9868237861609562
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23050,287,0.81 [0.65-1.02],0.071024111279565
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21515,407,1.09 [0.94-1.27],0.27008312368722
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19394,605,1.00 [0.87-1.15],0.988518664890722
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23463,205,0.86 [0.66-1.11],0.2418142913089979
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22673,42,1.23 [0.80-1.90],0.352759457665856
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Angina pectoris,22242,744,1.07 [0.96-1.20],0.2435590536111963
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22709,78,1.11 [0.79-1.57],0.5508841781055918
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22661,30,1.61 [1.11-2.33],0.0111140334756372
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22769,138,1.09 [0.83-1.43],0.53284379224735
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15291,1234,1.02 [0.93-1.12],0.6604647418394617
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,AV-block,20661,205,1.11 [0.90-1.37],0.310532043917812
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23506,265,0.86 [0.69-1.08],0.2029128937697347
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiac arrest,14162,105,1.33 [1.05-1.69],0.0169085852298464
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20570,114,0.79 [0.55-1.13],0.2017427040316367
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20525,69,0.89 [0.58-1.36],0.5822262519116141
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23544,27,1.11 [0.62-1.97],0.7301819292600311
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Conduction disorders,21075,619,1.11 [0.98-1.25],0.0978157977458403
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22762,1275,0.99 [0.90-1.09],0.8729865992420663
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21196,6248,1.06 [1.02-1.11],0.0018033963315039
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22270,218,0.91 [0.71-1.15],0.417239154973854
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Endocarditis,20502,46,1.13 [0.74-1.74],0.5703415584114209
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23462,714,1.05 [0.94-1.18],0.3796646283247498
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertension,21731,5263,1.06 [1.01-1.10],0.0113158007676965
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21740,5272,1.06 [1.01-1.10],0.0121284309312615
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23449,36,1.47 [1.05-2.06],0.0248782396755974
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16614,146,1.01 [0.77-1.33],0.951611208501559
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16533,65,1.18 [0.83-1.67],0.3468887067508492
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypotension,23431,909,1.00 [0.89-1.11],0.9360183159770048
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22898,80,0.86 [0.57-1.29],0.4658820760670916
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22942,1444,1.00 [0.92-1.09],0.956810445522378
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23277,391,1.02 [0.87-1.20],0.8051904711618307
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20721,265,1.05 [0.86-1.27],0.655645647323731
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23361,519,1.07 [0.94-1.22],0.3232170780774355
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21913,415,1.09 [0.94-1.27],0.2305928583924968
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23523,76,1.27 [0.95-1.69],0.1084754946701678
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23540,207,1.00 [0.80-1.26],0.976239007565609
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Oesophageal varices,22085,33,1.50 [1.05-2.15],0.0253927208088141
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other aneurysm,22680,49,0.95 [0.57-1.56],0.8252409023811246
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arrhythmias,20770,314,1.14 [0.97-1.34],0.1240658243771658
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22691,60,1.74 [1.42-2.14],9.017179351268269e-08
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22799,168,1.32 [1.10-1.60],0.0034138463015604
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20601,145,0.87 [0.65-1.18],0.3771178284649966
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other disorders of veins,22125,73,0.96 [0.64-1.43],0.8335558061810323
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22093,41,1.11 [0.70-1.75],0.6562518863893101
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22481,30,0.78 [0.38-1.59],0.4880121387392756
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22186,134,1.14 [0.88-1.47],0.3190419934571152
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21119,663,0.99 [0.87-1.13],0.9350936202195128
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22558,36,1.26 [0.82-1.95],0.2920250314561484
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23066,435,1.10 [0.95-1.27],0.2219745531518177
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23047,277,1.00 [0.83-1.22],0.9643553389940696
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22909,458,0.97 [0.83-1.14],0.7296633458403292
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14305,248,1.11 [0.91-1.34],0.2972772780638159
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22862,242,1.23 [1.03-1.46],0.0204964224248034
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22338,286,0.89 [0.72-1.10],0.2774246148990339
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23149,379,1.02 [0.87-1.21],0.7710132261841371
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23477,489,1.07 [0.93-1.23],0.3367905615995243
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20638,182,1.12 [0.90-1.39],0.304428563810216
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23040,270,1.01 [0.83-1.23],0.8830495327784325
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22581,130,0.88 [0.64-1.21],0.434177466295833
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23268,450,1.01 [0.86-1.17],0.9453802892181484
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23243,489,1.02 [0.88-1.18],0.8367905838316717
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22865,58,1.16 [0.80-1.69],0.4284774236193606
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22668,37,1.20 [0.75-1.91],0.4445595910293665
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23069,183,1.10 [0.88-1.37],0.4173266288908548
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23015,173,1.04 [0.81-1.32],0.7779922645532301
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Varicose veins,22432,380,1.07 [0.91-1.26],0.4068178283736569
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22640,80,0.76 [0.49-1.18],0.22308262320113
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23365,602,0.98 [0.85-1.12],0.754491177564168
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23511,188,1.09 [0.88-1.36],0.4322728510699118
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20923,1579,1.10 [1.02-1.19],0.0111057271074452
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Any mental disorder,23031,3687,1.05 [1.00-1.11],0.050347873915158
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23486,223,1.06 [0.86-1.30],0.597752566822251
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21042,1698,1.08 [1.01-1.17],0.0307682359407836
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19423,79,0.95 [0.64-1.39],0.7787744269776824
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Smoking dependency,23200,1024,1.09 [1.00-1.20],0.0604370800360374
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20531,1187,1.07 [0.98-1.17],0.1500823193605063
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Vascular dementia,23129,90,0.90 [0.62-1.31],0.5882355009132809
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Alzheimer disease,23546,317,0.80 [0.65-0.99],0.0438040774844308
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16123,49,0.64 [0.35-1.17],0.1453610166594423
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Bell's palsy,21703,68,0.60 [0.36-1.01],0.0554408688579501
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22191,556,0.98 [0.85-1.13],0.7993933794894371
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral cysts,23202,180,1.14 [0.92-1.41],0.2266380957401151
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23482,233,0.86 [0.68-1.09],0.2185542295565134
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23132,39,0.92 [0.53-1.61],0.7735921272814348
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23535,43,1.25 [0.84-1.84],0.2689207761847282
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23064,42,0.88 [0.50-1.54],0.6573498235826905
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Epilepsy,22289,242,0.96 [0.77-1.20],0.732784649345154
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23182,1135,0.97 [0.88-1.08],0.5965683542299167
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23503,307,0.93 [0.76-1.13],0.4647181342646468
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23014,2472,1.02 [0.96-1.09],0.55735849976045
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Generalized epilepsy,23236,41,1.17 [0.76-1.79],0.4716985788332792
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hemiplegia,23434,185,0.91 [0.70-1.18],0.4764839916141463
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hydrocephalus,23077,55,0.96 [0.61-1.50],0.8544165326273216
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23528,66,1.30 [0.97-1.75],0.0789870306242155
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21745,110,0.78 [0.54-1.13],0.1924359072158675
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21688,53,0.85 [0.51-1.40],0.5229056956518809
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Memory loss,23021,91,1.17 [0.88-1.56],0.2823745456763509
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Migraine,22486,439,0.99 [0.85-1.16],0.933287113757856
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23445,398,1.01 [0.85-1.18],0.9495451969058986
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Motor neuron disease,16214,116,1.10 [0.84-1.45],0.4914846646591412
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23348,124,0.89 [0.64-1.22],0.4573904020977516
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22835,1200,0.92 [0.83-1.02],0.1102758218709085
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Neurological diseases,22154,3176,0.95 [0.89-1.01],0.0830211823994634
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23216,123,0.95 [0.70-1.29],0.7228330288777729
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22000,365,0.93 [0.78-1.12],0.4586206365802178
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23495,191,1.06 [0.85-1.32],0.6144006341424246
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19039,569,0.89 [0.77-1.03],0.1295900251571667
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23079,57,1.09 [0.73-1.61],0.6813935615718675
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23131,109,0.92 [0.66-1.28],0.6257533020061212
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23336,140,1.01 [0.77-1.33],0.9559114958024268
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21711,76,0.57 [0.34-0.94],0.0262022950822897
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other headache syndromes,22111,64,1.15 [0.81-1.64],0.4328914376789571
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other neurological diseases,23446,424,1.07 [0.92-1.24],0.4049026003461888
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other sleep disorders,22389,342,0.93 [0.77-1.12],0.4275520700712065
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Parkinson's disease,23523,146,0.80 [0.58-1.10],0.1688793800970873
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23091,69,1.22 [0.88-1.69],0.2282411807237311
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Restless leg syndrome,23545,75,0.93 [0.62-1.39],0.7239633989912959
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Sleep apnoea,23393,275,0.93 [0.75-1.15],0.5000027107368366
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23338,34,1.34 [0.92-1.96],0.125180740112296
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23536,141,1.01 [0.76-1.32],0.9701068953960906
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21693,58,0.84 [0.52-1.37],0.4890098233424617
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23546,320,0.82 [0.66-1.01],0.057248655221079
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23089,87,0.88 [0.60-1.28],0.4968488212651655
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23042,91,0.91 [0.63-1.31],0.6048435152137119
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23155,411,0.99 [0.84-1.17],0.9165228184264118
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23422,138,1.11 [0.86-1.43],0.4256720632809102
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22585,52,1.18 [0.80-1.73],0.3955667902378142
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22580,47,0.97 [0.59-1.59],0.9039625172608728
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23440,55,1.22 [0.85-1.74],0.2852203721793113
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23304,143,0.91 [0.67-1.22],0.5304922427638177
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1456,28,0.94 [0.49-1.79],0.851023906876627
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1741,54,0.83 [0.50-1.36],0.4627001883257186
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23033,82,1.15 [0.84-1.58],0.3758894047406552
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23399,893,1.07 [0.97-1.19],0.1754276399268199
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23178,645,1.06 [0.94-1.20],0.3589137918834031
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22794,261,1.16 [0.98-1.38],0.090632454123235
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23472,728,0.98 [0.86-1.11],0.73133211321244
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23535,63,1.04 [0.70-1.54],0.8651607290209427
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23406,662,0.98 [0.86-1.12],0.8099616948360939
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23510,349,0.99 [0.83-1.18],0.886651396305002
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23463,178,1.04 [0.82-1.32],0.7227848077989971
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22569,36,0.96 [0.54-1.71],0.8903680796533848
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22573,40,1.24 [0.82-1.88],0.3022632319117145
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22595,62,1.09 [0.74-1.60],0.6779440460305689
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23468,613,0.91 [0.79-1.05],0.1818642910092269
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23004,149,0.78 [0.57-1.07],0.1259269436949378
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22800,56,0.72 [0.42-1.23],0.2317892051185005
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23247,86,1.05 [0.74-1.47],0.7874513215685557
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23434,273,0.98 [0.80-1.20],0.8752071999127709
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22924,180,1.13 [0.91-1.40],0.2550982940719243
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23401,116,0.87 [0.62-1.21],0.402581319399073
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23254,399,0.91 [0.77-1.09],0.3176999034864299
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23083,132,0.94 [0.69-1.27],0.6675067855541708
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22004,2181,1.04 [0.98-1.12],0.2085149172701815
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23400,239,1.01 [0.81-1.24],0.9572875884459998
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23526,139,1.27 [1.03-1.58],0.0264830367929204
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22865,332,1.09 [0.92-1.28],0.3386169037399835
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23219,58,1.09 [0.74-1.63],0.6548989889765173
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23521,49,1.17 [0.79-1.73],0.4428571108903216
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22613,80,1.08 [0.76-1.52],0.6780105208932562
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22661,128,1.09 [0.84-1.43],0.5099478696597963
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22595,89,1.22 [0.92-1.62],0.1678887305888851
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22800,56,1.05 [0.69-1.59],0.824789863497453
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22561,55,0.47 [0.25-0.87],0.0155772464249927
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22958,103,0.94 [0.67-1.31],0.7091229140585603
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23010,155,0.79 [0.58-1.08],0.1398181649885276
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22643,110,1.20 [0.92-1.55],0.1722617720293357
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22585,79,1.16 [0.85-1.59],0.3552530590823027
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22563,57,0.83 [0.50-1.37],0.4668933657112779
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21612,1789,1.00 [0.92-1.08],0.9790926731876014
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22608,75,1.26 [0.94-1.69],0.1181118724658932
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23321,370,1.02 [0.86-1.20],0.8397755859546152
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22992,41,1.06 [0.67-1.69],0.7905717190758845
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23097,146,1.12 [0.88-1.43],0.3607093679341633
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23325,98,0.82 [0.56-1.20],0.3098546168534301
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23505,94,0.90 [0.63-1.30],0.5768184325826354
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23441,124,1.15 [0.89-1.48],0.2893679565539718
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23291,64,1.23 [0.89-1.69],0.2151234275463127
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23294,67,1.01 [0.68-1.50],0.9686482413993212
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23455,690,1.09 [0.97-1.22],0.1549205229542815
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23234,469,1.09 [0.95-1.25],0.242413511887945
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22866,101,1.08 [0.80-1.46],0.5952138305819461
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22839,74,1.44 [1.14-1.83],0.0022941420927044
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute pharyngitis,23302,73,0.96 [0.65-1.43],0.845353084867619
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23438,209,0.92 [0.73-1.18],0.5252704645992052
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23287,58,1.02 [0.67-1.56],0.91529032183175
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza,22103,112,1.02 [0.75-1.38],0.9138734187675606
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22102,111,1.03 [0.76-1.40],0.8354173684987483
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16763,113,0.90 [0.65-1.26],0.5547832268471266
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic rhinitis,23425,246,0.98 [0.80-1.21],0.8774316189779456
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18285,1795,1.05 [0.98-1.13],0.157216595837207
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18421,1771,1.05 [0.98-1.14],0.1526090414617118
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23190,115,1.14 [0.87-1.48],0.3359407261730638
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22051,60,1.21 [0.86-1.68],0.2728299083568379
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bronchiectasis,20340,341,1.14 [0.97-1.33],0.1025949490697947
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20059,60,0.89 [0.56-1.41],0.6205645676889381
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22554,2555,1.05 [0.98-1.11],0.149217682380067
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22442,57,1.08 [0.73-1.62],0.6931682169540254
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic sinusitis,22511,126,1.11 [0.86-1.45],0.4281424046342605
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23398,889,1.02 [0.91-1.13],0.7494839743578562
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Deviated nasal septum,22450,65,0.83 [0.52-1.33],0.4448885555610221
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21752,4396,1.03 [0.98-1.08],0.2615804154646281
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22678,293,1.01 [0.84-1.22],0.9028579728247164
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Early onset COPD,22782,273,1.12 [0.96-1.32],0.1492274684499532
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Emphysema,20226,227,1.16 [0.97-1.39],0.1089767108695604
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22088,200,1.06 [0.85-1.32],0.6055507347371742
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23374,1383,0.97 [0.89-1.06],0.5430051268937756
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Interstitial lung disease,22123,235,1.01 [0.82-1.25],0.940694519082691
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Later onset COPD,22756,616,0.97 [0.85-1.11],0.6362930037745905
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23540,185,0.96 [0.75-1.23],0.7264010901817994
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Nasal polyp,22443,58,1.10 [0.74-1.63],0.6340595043649297
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23347,792,0.98 [0.87-1.10],0.7380973764547305
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of pleura,23384,1489,1.07 [0.99-1.16],0.1100544406145412
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23067,682,1.10 [0.98-1.24],0.0897481093781966
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other pleural conditions,21929,34,0.78 [0.40-1.50],0.4545951078227467
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23471,297,1.04 [0.86-1.25],0.7062442992653142
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23467,1014,1.06 [0.96-1.16],0.2691395176680677
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural effusion,22597,702,1.07 [0.95-1.20],0.2748332773971301
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural plaque,21938,43,1.26 [0.86-1.85],0.2316460524399892
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23166,1175,0.95 [0.86-1.05],0.334671107138721
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23514,159,0.99 [0.76-1.28],0.931054195803708
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumothorax,21982,87,1.18 [0.88-1.57],0.2679833294716285
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pollen allergy,23521,207,0.97 [0.77-1.23],0.822162007880332
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pulmonary oedema,23227,53,1.31 [0.95-1.81],0.0970086060148108
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16693,43,1.15 [0.74-1.80],0.5240311500687548
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23328,773,0.96 [0.85-1.09],0.5484046967747953
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22631,246,0.99 [0.80-1.22],0.910749074102069
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Viral pneumonia,22173,182,0.88 [0.68-1.16],0.3683340547688287
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23196,142,0.78 [0.56-1.08],0.1276023527497763
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11349,90,1.23 [0.92-1.63],0.1587289716838398
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16830,34,0.97 [0.54-1.72],0.9037952625619574
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute appendicitis,23378,115,0.74 [0.51-1.07],0.1098079432776418
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute gastritis,17701,74,0.84 [0.55-1.30],0.4353617356682094
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute pancreatitis,21586,140,1.15 [0.91-1.46],0.2345224090549783
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute peritonitis,23062,72,1.37 [1.06-1.77],0.0155171326186424
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22817,31,1.43 [1.00-2.04],0.0474621584860536
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Barrett oesophagus,17918,291,1.06 [0.89-1.27],0.5010602018682232
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21513,67,1.37 [1.03-1.81],0.0289213079938028
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23188,67,1.37 [1.04-1.81],0.0275373377747894
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholecystitis,21598,152,1.18 [0.94-1.47],0.153273453814885
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholelithiasis,22480,1034,0.97 [0.88-1.08],0.5938415892157753
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic gastritis,17917,290,1.03 [0.86-1.24],0.7414005561226695
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21482,36,0.98 [0.57-1.71],0.9548754687985958
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23477,64,1.21 [0.86-1.70],0.266553764468014
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Coeliac disease,22232,124,1.34 [1.09-1.64],0.0052965655605254
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Collagenous colitis,21924,89,0.74 [0.49-1.13],0.1678728324854713
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23425,140,1.06 [0.82-1.38],0.6360595490236198
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Constipation,23252,1456,0.97 [0.89-1.06],0.5159813690374127
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn disease,21906,71,0.96 [0.64-1.44],0.8403359814742527
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23238,49,1.05 [0.67-1.64],0.8255424658328578
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21909,74,0.83 [0.53-1.28],0.3950838749151403
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Dental caries,22834,197,1.09 [0.88-1.35],0.4296776253055386
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22148,2091,1.07 [1.00-1.14],0.0631217000587182
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of appendix,23415,152,0.88 [0.65-1.17],0.3729297520784512
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of liver,23462,676,1.05 [0.93-1.19],0.3996911292341919
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21569,3942,1.05 [1.00-1.10],0.0538008129069166
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23141,504,1.10 [0.97-1.26],0.1420453461871025
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23437,447,1.07 [0.93-1.24],0.335797133310469
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22735,98,0.78 [0.53-1.15],0.2142741412147339
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22608,55,1.13 [0.76-1.67],0.5472552283100458
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23292,1184,1.00 [0.91-1.10],0.9310092655198096
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of tongue,22614,88,1.02 [0.73-1.44],0.8929155439269418
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22816,1370,1.03 [0.94-1.12],0.5160040179802352
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19548,2752,1.02 [0.96-1.08],0.507300045823706
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Duodenal ulcer,17742,115,1.20 [0.94-1.54],0.1478284597567751
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23497,95,1.02 [0.73-1.42],0.9152545996738728
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23463,55,1.29 [0.94-1.78],0.1194633144706721
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22867,81,1.24 [0.92-1.66],0.1546821273350031
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16898,102,1.01 [0.73-1.38],0.9724278594205892
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Functional dyspepsia,18200,573,1.09 [0.96-1.23],0.1973509584489856
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastric ulcer,17926,299,1.00 [0.83-1.21],0.9941765421233
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20002,2375,1.02 [0.95-1.09],0.6583440340253954
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18040,413,1.08 [0.93-1.25],0.3199972633278964
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18412,7211,1.04 [1.00-1.08],0.0398163947028039
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,GI-bleeding,23053,945,0.95 [0.85-1.06],0.3260977714995822
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22697,60,0.92 [0.58-1.45],0.7150594235235617
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17639,1094,1.05 [0.95-1.15],0.3208850293584631
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22817,31,0.77 [0.39-1.56],0.4740692605885271
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Hernia,22529,2472,1.06 [1.00-1.13],0.0602383364093901
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impacted teeth,23471,50,1.41 [1.06-1.88],0.0185028893914788
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impaction of intestines,16856,60,1.25 [0.90-1.71],0.1781605697448056
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Inguinal hernia,20202,145,0.99 [0.75-1.31],0.96077542931606
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16877,81,1.15 [0.85-1.57],0.3714686191840215
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22258,150,1.26 [1.02-1.54],0.0296216935743261
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17486,690,1.06 [0.94-1.19],0.3413888840531052
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23537,296,1.13 [0.95-1.34],0.1579157899163567
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22528,693,1.18 [1.06-1.31],0.0025791907499452
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22767,932,1.13 [1.02-1.24],0.0150061512708198
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17756,129,1.18 [0.93-1.50],0.1783013155722138
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophagitis,18113,486,0.88 [0.75-1.04],0.1312187144315565
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23505,136,0.87 [0.64-1.19],0.3938210899542991
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20109,52,1.27 [0.91-1.79],0.165049148002546
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17876,1080,0.96 [0.87-1.07],0.4798074501752102
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21698,252,1.05 [0.86-1.28],0.6169957413610335
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21608,162,0.92 [0.70-1.21],0.5604474746040425
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestine,18150,1354,0.98 [0.89-1.07],0.5989241724503689
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestines,21672,4876,0.99 [0.95-1.04],0.8172521526243761
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22612,197,0.98 [0.77-1.24],0.842459515753805
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of liver,23350,564,1.06 [0.93-1.21],0.4019975549565061
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18126,499,1.09 [0.96-1.25],0.1961536041946681
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21576,130,0.99 [0.74-1.32],0.9521672622713574
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23382,392,1.01 [0.85-1.18],0.9503747300952636
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18546,919,1.12 [1.01-1.23],0.0252286782966013
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23068,960,0.95 [0.85-1.06],0.3605750803296064
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22786,149,1.15 [0.91-1.45],0.2511238862619804
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18302,1506,0.99 [0.91-1.07],0.7436959097124018
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19423,1796,1.08 [1.00-1.16],0.0463105440076928
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22873,87,1.15 [0.84-1.56],0.386521587520479
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22656,821,1.12 [1.01-1.24],0.0306916728055429
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17082,286,0.98 [0.81-1.19],0.8762465915998132
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23453,64,1.21 [0.87-1.67],0.2564323887020018
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17221,425,0.97 [0.83-1.14],0.7326752182512368
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22227,119,1.14 [0.88-1.48],0.3276344555577417
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23538,63,0.90 [0.58-1.41],0.6563408265543449
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22636,113,1.01 [0.75-1.37],0.9383128390860616
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Toxic colitis,21890,55,0.94 [0.59-1.50],0.7933843980256756
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17835,208,0.95 [0.75-1.20],0.6414364725638626
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcerative colitis,21982,147,1.16 [0.92-1.46],0.2044669205425276
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21959,124,1.25 [0.99-1.57],0.055893165709396
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Umbilical hernia,20205,148,0.84 [0.61-1.14],0.2535129106346183
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16960,164,0.85 [0.64-1.12],0.2540171231737566
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ventral hernia,20272,215,0.98 [0.78-1.23],0.868546496700322
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Volvulus,16868,72,0.93 [0.62-1.39],0.7099666311608006
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23471,216,1.23 [1.03-1.47],0.0236521054193912
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23269,77,0.77 [0.49-1.20],0.2454754672983379
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21794,196,1.03 [0.82-1.29],0.8204200639424466
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23078,543,1.03 [0.89-1.18],0.7011179390914946
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22662,127,0.91 [0.67-1.24],0.5454244786038496
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21875,277,0.94 [0.76-1.16],0.5815790009027599
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23271,240,1.08 [0.89-1.31],0.4329178221217072
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23449,418,1.05 [0.90-1.22],0.5376484048625749
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23075,44,1.35 [0.95-1.90],0.0896888431239446
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22182,2733,1.02 [0.95-1.08],0.6288459906264464
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23165,402,0.92 [0.77-1.09],0.3305579360175001
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23036,273,0.97 [0.80-1.19],0.8022131505382848
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23265,730,0.99 [0.88-1.12],0.8863785886495146
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23528,66,1.15 [0.81-1.63],0.4347971047230685
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21686,88,0.88 [0.60-1.30],0.524150178710989
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22804,41,0.92 [0.54-1.59],0.7760233020117168
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23257,226,1.09 [0.89-1.33],0.3946688443079137
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21957,359,1.02 [0.86-1.21],0.7862973239442371
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21643,45,0.94 [0.56-1.58],0.8052284714202201
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23457,68,1.02 [0.69-1.50],0.9272978757403438
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22664,129,1.07 [0.81-1.40],0.6329202748835909
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23342,150,0.65 [0.46-0.91],0.0127757934628419
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23074,43,0.91 [0.53-1.56],0.725415022528141
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21654,56,1.02 [0.66-1.57],0.9299227992307288
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22969,1371,1.06 [0.97-1.15],0.1909572686727676
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21988,390,1.11 [0.95-1.29],0.1950623002535819
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21647,49,1.10 [0.71-1.70],0.6629622792694237
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23474,282,0.86 [0.69-1.07],0.1696552795419024
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23105,74,0.87 [0.57-1.33],0.5265463870184088
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23411,219,0.77 [0.59-1.00],0.0463140230957762
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23498,243,1.17 [0.98-1.40],0.0912245091500017
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21741,143,1.04 [0.80-1.36],0.7611832687310095
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21821,223,1.11 [0.91-1.35],0.3099218821526879
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23486,231,1.18 [0.98-1.42],0.0830682483031426
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21768,170,1.31 [1.09-1.58],0.0042702630228414
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23514,125,1.05 [0.79-1.39],0.7358886554752815
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20085,116,1.22 [0.95-1.56],0.11418010563371
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21374,5488,1.03 [0.99-1.08],0.1196738246551956
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20191,4305,1.05 [1.00-1.10],0.0670432803008431
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20033,64,1.41 [1.08-1.84],0.0104605654837062
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20203,134,1.11 [0.86-1.43],0.4312561725627666
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20247,178,1.01 [0.80-1.29],0.9133809107514764
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23298,101,1.13 [0.85-1.50],0.4072391162768687
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20169,100,0.85 [0.58-1.22],0.3745245296039521
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17077,1191,1.06 [0.97-1.15],0.217475651225409
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23410,200,1.17 [0.96-1.42],0.1209497779428737
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20567,498,1.00 [0.86-1.16],0.9736025800120188
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19768,6995,1.03 [0.99-1.07],0.1055070577230655
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21086,122,1.06 [0.79-1.41],0.7043698934914145
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20087,118,0.98 [0.72-1.33],0.8759725533195979
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20562,593,1.00 [0.88-1.15],0.9603166821575964
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22665,2596,1.01 [0.95-1.07],0.803404079940623
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20121,152,0.97 [0.74-1.28],0.8463667585960555
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20300,331,1.06 [0.89-1.25],0.5270289302940936
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20120,151,1.01 [0.78-1.32],0.935328842456712
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22690,94,0.93 [0.65-1.34],0.7022713525897599
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17516,1630,1.07 [0.99-1.16],0.0800276729274665
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16064,178,1.07 [0.85-1.34],0.5884438968735514
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23533,175,1.06 [0.84-1.35],0.6103668967377553
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15975,89,0.80 [0.54-1.20],0.2861147559876492
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16383,497,0.91 [0.77-1.06],0.2181462304300517
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20257,288,0.91 [0.74-1.12],0.3687055153907854
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16442,556,1.11 [0.98-1.26],0.0922489963723112
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20126,57,1.08 [0.72-1.62],0.7175208087679894
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20689,620,1.02 [0.90-1.16],0.7472684163248152
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20358,289,0.90 [0.73-1.11],0.3336941235678768
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16402,516,1.13 [1.00-1.28],0.0575951515354603
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20042,73,1.29 [0.97-1.72],0.078132483710892
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20027,58,1.30 [0.94-1.79],0.1150917647697336
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21007,43,0.89 [0.51-1.55],0.6858035939516218
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23136,2172,1.06 [0.99-1.13],0.1091467300937061
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22527,1563,1.05 [0.97-1.14],0.2034167054884228
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23368,517,1.00 [0.86-1.15],0.9790486173156738
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18518,2632,1.03 [0.96-1.09],0.4119845028085583
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15946,60,0.93 [0.60-1.46],0.7544821292327111
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20057,88,0.82 [0.55-1.23],0.3364984361627887
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15927,41,1.12 [0.71-1.75],0.6331234143722293
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16065,179,1.14 [0.93-1.41],0.2112666241665907
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21223,259,1.12 [0.93-1.35],0.2234536583747924
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21450,486,1.01 [0.87-1.17],0.9418958946668212
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23522,92,0.97 [0.68-1.38],0.8744108273494805
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21828,1759,1.03 [0.95-1.11],0.4486509239085471
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20081,112,0.91 [0.65-1.27],0.5622267914942216
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16092,206,0.77 [0.59-1.01],0.0606300075811448
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20767,698,0.95 [0.83-1.08],0.4055318814138948
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18080,2194,1.01 [0.94-1.08],0.7593664106369624
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22708,112,0.98 [0.71-1.35],0.9136369837514388
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23529,75,0.83 [0.54-1.28],0.3944038031504351
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20035,66,0.92 [0.60-1.42],0.7081752911234405
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21239,1270,1.05 [0.96-1.15],0.2729669128132369
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20041,72,1.22 [0.89-1.66],0.2256147884918643
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17595,1709,1.05 [0.97-1.13],0.2169644424937786
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21091,127,1.11 [0.85-1.45],0.4269711100748935
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20016,47,1.00 [0.62-1.62],0.9969816674399408
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20243,174,0.95 [0.73-1.23],0.6796847396553657
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20474,505,1.08 [0.94-1.23],0.2914556584440678
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23042,446,1.12 [0.98-1.29],0.1014468315675559
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20624,555,0.95 [0.82-1.10],0.4806918465479275
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23378,499,1.01 [0.87-1.17],0.8965916491934328
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23520,58,1.09 [0.74-1.62],0.6619416383567558
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20160,191,0.90 [0.70-1.17],0.4364658045396773
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18052,780,1.04 [0.93-1.17],0.5079355006097213
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20537,568,1.00 [0.88-1.15],0.9456072733735889
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20071,102,1.08 [0.80-1.45],0.6210243670677822
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15958,72,0.98 [0.67-1.44],0.933161494312227
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18165,2279,1.04 [0.98-1.11],0.2020586151766878
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16611,725,1.03 [0.92-1.16],0.6284072878173177
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22849,253,1.01 [0.82-1.24],0.9351133732374184
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23498,68,0.95 [0.63-1.44],0.8109120632380623
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21555,47,0.96 [0.58-1.59],0.8891576050234453
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15962,76,0.84 [0.55-1.29],0.426638758801124
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20167,98,1.08 [0.79-1.47],0.6351743991527694
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16407,521,1.00 [0.87-1.16],0.9564461228652152
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20246,277,0.85 [0.68-1.06],0.1580508137846817
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20313,244,1.33 [1.15-1.55],0.0001659840351081
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20308,239,1.00 [0.81-1.24],0.9814119590945084
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18144,77,0.96 [0.65-1.42],0.8319211391453138
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23526,64,0.96 [0.63-1.46],0.8340717785690328
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20517,548,0.99 [0.86-1.14],0.8598443107960805
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22745,149,1.27 [1.03-1.56],0.0231693739474795
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22399,2430,1.00 [0.94-1.07],0.9667493544695748
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20103,134,0.87 [0.64-1.19],0.3860104160686646
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20543,474,1.03 [0.89-1.20],0.691849561844582
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22027,225,0.97 [0.78-1.22],0.8066077404022887
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20279,210,1.07 [0.86-1.32],0.5623018054368489
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21552,1483,1.00 [0.92-1.09],0.995458730961906
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21076,1007,1.01 [0.91-1.12],0.8413181648105407
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20024,55,0.59 [0.33-1.06],0.0790152195584728
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22808,212,1.07 [0.86-1.32],0.5460202059099784
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20142,173,1.00 [0.78-1.28],0.9981204578956504
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20082,113,0.97 [0.70-1.33],0.8397909384096144
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15930,44,0.89 [0.52-1.51],0.6665133064445938
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22719,1027,1.09 [0.99-1.20],0.0763272262645501
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17606,86,1.15 [0.85-1.57],0.3607073583605501
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22949,98,0.85 [0.59-1.23],0.3996733232366162
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23410,196,1.02 [0.81-1.29],0.8351338075241254
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23236,22,0.64 [0.26-1.57],0.3347048216671809
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22834,1142,1.03 [0.94-1.13],0.5221719331297945
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23407,58,0.98 [0.62-1.52],0.9145278160294154
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23376,199,0.81 [0.62-1.07],0.1344810085686437
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cystitis,20807,215,0.95 [0.75-1.20],0.6813290123067186
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Dialysis,21735,43,1.50 [1.12-2.02],0.0069600822114424
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23131,280,0.97 [0.80-1.19],0.7784289092587926
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Endometriosis,17668,148,1.10 [0.86-1.40],0.4487190894353974
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17861,341,0.82 [0.68-1.01],0.0576946915235013
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18383,863,1.06 [0.95-1.17],0.31966039072728
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18308,4247,1.07 [1.02-1.12],0.0053284657823298
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23399,50,1.02 [0.65-1.61],0.91952888178438
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21571,181,0.82 [0.62-1.09],0.1760459121383448
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23077,343,1.03 [0.87-1.23],0.6963564141526879
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Irregular menses,23150,110,0.87 [0.62-1.22],0.4259212911352512
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17787,267,0.87 [0.71-1.08],0.2189024786383012
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20656,64,1.07 [0.72-1.58],0.7366426546963424
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19624,2104,1.02 [0.95-1.09],0.6072404111529436
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17638,118,1.00 [0.75-1.35],0.9771561636038912
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23537,57,1.23 [0.86-1.75],0.2539592633703534
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23537,67,0.82 [0.52-1.30],0.3902881714988248
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22478,1886,1.07 [1.00-1.15],0.0594511668993651
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20997,405,1.13 [0.97-1.30],0.1067361860384917
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22951,100,1.01 [0.73-1.39],0.9683186062448504
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23496,319,1.04 [0.87-1.24],0.6946129612130324
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23494,74,1.07 [0.75-1.53],0.7203530608229964
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22204,1612,1.04 [0.97-1.13],0.2765086976222132
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22912,178,1.07 [0.85-1.34],0.5731910202778747
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17656,136,1.19 [0.94-1.51],0.1422370429841247
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17858,338,1.07 [0.91-1.27],0.3950066489496183
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17621,101,1.02 [0.74-1.41],0.8940452983770986
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17696,176,0.98 [0.76-1.26],0.848201591216051
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21615,225,0.95 [0.76-1.19],0.6688496356996654
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23282,105,1.13 [0.86-1.50],0.3834229647439476
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17783,263,1.17 [0.99-1.39],0.0712291560786682
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17610,90,1.03 [0.74-1.43],0.8605087129860015
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18073,553,1.06 [0.93-1.21],0.3552930418847331
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17656,136,1.15 [0.90-1.47],0.2681860940147368
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18026,506,0.94 [0.80-1.09],0.410477128422634
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23382,33,0.92 [0.50-1.66],0.7728209226019808
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23395,2005,1.05 [0.98-1.13],0.1440367066470916
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21538,148,1.13 [0.89-1.44],0.297843382366723
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21772,80,1.31 [1.00-1.72],0.0512551345706786
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23242,28,0.85 [0.43-1.71],0.6572864648171335
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20719,127,1.27 [1.02-1.59],0.031649358167219
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23437,223,1.00 [0.80-1.25],0.9982489986923552
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17638,118,1.24 [0.99-1.56],0.0625461738042668
